KS100

Research use only, not for human use.

KS100 is a selective and potent ALDH inhibitor with antiproliferative and anticancer activities.KS100 inhibits ALDH1A1, ALDH2 and ALDH3A1 with IC50 of 334, 2137 and 360 nM, respectively.

KS100 is a potent ALDH inhibitor with IC50s of 230, 1542, 193 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively. KS100 shows antiproliferative and anticancer effects with low low toxic. KS100 significantly increases ROS activity, lipid peroxidation and toxic aldehyde accumulation. KS10600 induces apoptosis and cell cycle arrest at the G2/M phase.

KS100 (compound 3j) (0-100 μM; 72 h) shows anti-proliferative activity with IC50s of 3.7, 2.1, 2.9, 2.5, 0.3, 1.0, 1.2, 1.3, 2.1, 9.8 μM for UACC 903, 1205 Lu, HCT116, HT29, NCIH929, U266, RPMI8226, MM.1R, MM.1S, FF2441 cells, respectively.KS100 (5 μM, 24 h) induces apoptosis and cell cycle arrest at the G2/M phase.Apoptosis Analysis Cell Line:HCT116, HT29 cells Concentration:5 μM Incubation Time:24 h Result:Induced cell apoptosis.Apoptosis Analysis Cell Line:HCT116 cells Concentration:5 μM Incubation Time:24 hResult:Induced cell cycle arrest at G2/M phase.

——

——

Metabolic Enzyme/Protease

Dehydrogenase

Dehydrogenase

——

——

2408477-54-1

564.09

C17H14Br3N3O2S

>98% (HPLC)

In Vitro:?DMSO : 125 mg/mL (221.60 mM; Ultrasonic )

Br.O=C1C(=O)N(C=2C(Br)=CC(Br)=CC12)CC3=CC=C(C=C3)CSC(=N)N

——

(-20℃)

With Ice Pack

≥ 2 years